HSP90AA1 and melanoma: The inhibition of secreted HSP90AA1 with chemical inhibitors, such as 17-allylamino-17 demethoxygeldanamycin (17AAG) and monoclonal antibody against HSP90AA1 (mAb 4C5), thus reduced in vitro invasion and metastasis in mouse melanoma models [133,134].